U.S. Longevity Diagnostics Market Size & Outlook, 2026-2033

Name: U.S. Longevity Diagnostics Market Size & Outlook
Creator: Grand View Research
License: https://www.grandviewresearch.com/horizon/info/terms-of-use

The longevity diagnostics market in the United States is expected to reach a projected revenue of US$ 1,674.7 million by 2033. A compound annual growth rate of 6.1% is expected of the United States longevity diagnostics market from 2026 to 2033.

U.S. longevity diagnostics test type outlook (Revenue, USD million, 2021-2033)
- Epigenetic Age Testing
- Telomere Length Analysis
- Multi-Omics Profiling
- Proteomics-Based Aging Biomarkers
- Metabolomics Testing
- Microbiome Aging Diagnostics
- Hormone & Metabolic Profiling
U.S. longevity diagnostics technology outlook (Revenue, USD million, 2021-2033)
- Next-Generation Sequencing (NGS)
- Mass Spectrometry
- AI-Powered Analytics
- Microarray Technology
- Wearable-Integrated Monitoring
U.S. longevity diagnostics end use outlook (Revenue, USD million, 2021-2033)
- Direct-to-Consumer (DTC)
- Longevity Clinics
- Hospitals & Clinical Laboratories
- Others

U.S. Longevity Diagnostics Market Size & Outlook, 2026-2033

Sign up - it's easy, and free!